Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Neurology Software Market by Component (Software, Services), by Deployment Model (On-Premises, Cloud), by Enterprise Size (Large Enterprises, Small Medium Enterprises), by Type (Type I, Type II) and by End User (Hospitals, College Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A14697

Pages: NA

Charts: NA

Tables: NA

Neurology software is a specialized healthcare software that is used by neurologists, neurosurgeons, and neurology hospitals which facilitates them to meet their particular needs by offering specialized work processes. The software makes use of pre-installed notes templates for common practices which ensure documentation of pre-operative and post-operative treatment and certain content for patient evaluation, medication management, and others. A customizable neurology software platform helps to automate operations, prevents termination, and collects & reports data effectively. The software helps to save time and resources with smooth communication between labs, radiology, pharmacies, and doctors. The software boosts efficiency and increases revenue and helps to be more responsive to the needs of the patients and doctors. The software improves the practice efficiency by automating work processes, with pre-built templates, including forms, notes, lab orders, and others. The software facilitates online appointment scheduling with a reminder feature and provides instant access to the patient's medical records and assist in smooth collection and reporting of data of patient health information.  

COVID-19 Scenario Analysis: 

  • The spread of COVID-19 has adversely affected the industries and global economies. The imposed lockdown by the government has affected the supply chain due to the limited transportation. COVID guidelines and restrictions for travel have aggravated the situation. However, the healthcare sector has seen significant growth owing to the adoption of the latest technologies during the pandemic situation.
  • The neurology software market has observed a significant growth during the pandemic situation owing to the adoption of neurology software by the hospitals to facilitate neurosurgeons and doctors to treat the patients remotely from their respective places by accessing the detailed patient information. The software helps to connect hospitals, pharmacies, and labs for smooth communication between them.  

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers, and Impact Analysis

The rise in the need to automate time-consuming administrative tasks, easy accessibility to the patient’s health information, and integration of advanced technologies to facilitate healthcare services are the factors driving the growth of the neurology software market. In addition, the ability of the software to provide smooth communication between labs, radiology, pharmacies, and referring doctors is propelling the market growth. However, the lack of technical expertise and high implementation and maintenance costs of the software are the factors hampering the growth of the market. Furthermore, the increasing demand for cost-effective cloud-based or server-based solutions to ease the functionality of the software is providing lucrative opportunities to the growth of the neurology software market in the forecasted period. 

The Market Trends for Neurology Software Market:

Adoption of the Software by Various Healthcare Companies Drives the Market Growth:

The neurology software is being adopted by various industry sectors including healthcare, college & research institutes, and others. Healthcare companies are expected to adopt the software to provide better facilities in terms of medication and prescription and others to their patients. The software is helping to automate the administrative tasks which are time-consuming and require a lot of spending. The software helps to provide real-time health information of the patient which facilitates the doctors to prescribe medicines accordingly. The increased adoption of software by healthcare companies drives the growth of the market.  

Cloud-based Software Solutions to Drive the Market Growth:

The adoption of the latest technologies such as cloud-based or web-based software solutions is facilitating the growth of the neurology software market in the forecasted period. Cloud-based software solutions are increasingly being implemented in the healthcare sector because these solutions are cost-effective, flexible, easy to install without requiring any hardware component, and is easily accessible with the devices having an internet connection. The cloud software can be accessed from remote locations and facilitate doctors and patients to interact virtually instead of physical interactions. 

Key Benefits of the Report:

  • This study presents an analytical depiction of the neurology software market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the neurology software market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the neurology software market. 
  • The report provides a detailed market analysis based on the present and future competitive intensity of the market. 

Questions Answered in the Neurology Software Market Research Report:

  • Who are the leading market players active in neurology software market?
  • What would be the detailed impact of COVID-19 on the neurology software market?
  • What current trends would influence the market in the next few years??
  • What are the driving factors, restraints, and opportunities in the neurology software market?
  • What are the projections for the future that would help in taking further strategic steps?

Key Market Segments

  • By Component
    • Software
    • Services
  • By Deployment Model
    • On-Premises
    • Cloud
  • By Enterprise Size
    • Large Enterprises
    • Small & Medium Enterprises
  • By Type
    • Type I
    • Type II
  • By End User
    • Hospitals
    • College & Research Institutes
    • Others
  • By Region
    • North America
      • U.S
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Rest of Asia-Pacific
    • Latin America
    • Middle East
    • Africa


Key Market Players

  • Practice Fusion Inc
  • Athenahealth
  • NextGen Healthcare Information Systems LLC
  • Bizmatics
  • Kareo Inc
  • Epic Neuro Inc
  • Brainlab AG
  • Greenway Health LLC
  • Allscripts Healthcare Solutions Inc.
  • HealthFusion Inc.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NEUROLOGY SOFTWARE MARKET, BY COMPONENT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Component

    • 4.2. Software

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Services

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROLOGY SOFTWARE MARKET, BY DEPLOYMENT MODEL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Deployment Model

    • 5.2. On-Premises

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cloud

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROLOGY SOFTWARE MARKET, BY ENTERPRISE SIZE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Enterprise Size

    • 6.2. Large Enterprises

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Small And Medium Enterprises

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROLOGY SOFTWARE MARKET, BY TYPE

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Type

    • 7.2. Type I

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Type II

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

  • CHAPTER 8: NEUROLOGY SOFTWARE MARKET, BY END USER

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By End User

    • 8.2. Hospitals

      • 8.2.1. Key Market Trends, Growth Factors and Opportunities

      • 8.2.2. Market Size and Forecast, By Region

      • 8.2.3. Market Share Analysis, By Country

    • 8.3. College And Research Institutes

      • 8.3.1. Key Market Trends, Growth Factors and Opportunities

      • 8.3.2. Market Size and Forecast, By Region

      • 8.3.3. Market Share Analysis, By Country

    • 8.4. Others

      • 8.4.1. Key Market Trends, Growth Factors and Opportunities

      • 8.4.2. Market Size and Forecast, By Region

      • 8.4.3. Market Share Analysis, By Country

  • CHAPTER 9: NEUROLOGY SOFTWARE MARKET, BY REGION

    • 9.1. Market Overview

      • 9.1.1 Market Size and Forecast, By Region

    • 9.2. North America

      • 9.2.1. Key Market Trends and Opportunities

      • 9.2.2. Market Size and Forecast, By Component

      • 9.2.3. Market Size and Forecast, By Deployment Model

      • 9.2.4. Market Size and Forecast, By Enterprise Size

      • 9.2.5. Market Size and Forecast, By Type

      • 9.2.6. Market Size and Forecast, By End User

      • 9.2.7. Market Size and Forecast, By Country

      • 9.2.8. U.S. Neurology Software Market

        • 9.2.8.1. Market Size and Forecast, By Component
        • 9.2.8.2. Market Size and Forecast, By Deployment Model
        • 9.2.8.3. Market Size and Forecast, By Enterprise Size
        • 9.2.8.4. Market Size and Forecast, By Type
        • 9.2.8.5. Market Size and Forecast, By End User
      • 9.2.9. Canada Neurology Software Market

        • 9.2.9.1. Market Size and Forecast, By Component
        • 9.2.9.2. Market Size and Forecast, By Deployment Model
        • 9.2.9.3. Market Size and Forecast, By Enterprise Size
        • 9.2.9.4. Market Size and Forecast, By Type
        • 9.2.9.5. Market Size and Forecast, By End User
      • 9.2.10. Mexico Neurology Software Market

        • 9.2.10.1. Market Size and Forecast, By Component
        • 9.2.10.2. Market Size and Forecast, By Deployment Model
        • 9.2.10.3. Market Size and Forecast, By Enterprise Size
        • 9.2.10.4. Market Size and Forecast, By Type
        • 9.2.10.5. Market Size and Forecast, By End User
    • 9.3. Europe

      • 9.3.1. Key Market Trends and Opportunities

      • 9.3.2. Market Size and Forecast, By Component

      • 9.3.3. Market Size and Forecast, By Deployment Model

      • 9.3.4. Market Size and Forecast, By Enterprise Size

      • 9.3.5. Market Size and Forecast, By Type

      • 9.3.6. Market Size and Forecast, By End User

      • 9.3.7. Market Size and Forecast, By Country

      • 9.3.8. France Neurology Software Market

        • 9.3.8.1. Market Size and Forecast, By Component
        • 9.3.8.2. Market Size and Forecast, By Deployment Model
        • 9.3.8.3. Market Size and Forecast, By Enterprise Size
        • 9.3.8.4. Market Size and Forecast, By Type
        • 9.3.8.5. Market Size and Forecast, By End User
      • 9.3.9. Germany Neurology Software Market

        • 9.3.9.1. Market Size and Forecast, By Component
        • 9.3.9.2. Market Size and Forecast, By Deployment Model
        • 9.3.9.3. Market Size and Forecast, By Enterprise Size
        • 9.3.9.4. Market Size and Forecast, By Type
        • 9.3.9.5. Market Size and Forecast, By End User
      • 9.3.10. Italy Neurology Software Market

        • 9.3.10.1. Market Size and Forecast, By Component
        • 9.3.10.2. Market Size and Forecast, By Deployment Model
        • 9.3.10.3. Market Size and Forecast, By Enterprise Size
        • 9.3.10.4. Market Size and Forecast, By Type
        • 9.3.10.5. Market Size and Forecast, By End User
      • 9.3.11. Spain Neurology Software Market

        • 9.3.11.1. Market Size and Forecast, By Component
        • 9.3.11.2. Market Size and Forecast, By Deployment Model
        • 9.3.11.3. Market Size and Forecast, By Enterprise Size
        • 9.3.11.4. Market Size and Forecast, By Type
        • 9.3.11.5. Market Size and Forecast, By End User
      • 9.3.12. UK Neurology Software Market

        • 9.3.12.1. Market Size and Forecast, By Component
        • 9.3.12.2. Market Size and Forecast, By Deployment Model
        • 9.3.12.3. Market Size and Forecast, By Enterprise Size
        • 9.3.12.4. Market Size and Forecast, By Type
        • 9.3.12.5. Market Size and Forecast, By End User
      • 9.3.13. Russia Neurology Software Market

        • 9.3.13.1. Market Size and Forecast, By Component
        • 9.3.13.2. Market Size and Forecast, By Deployment Model
        • 9.3.13.3. Market Size and Forecast, By Enterprise Size
        • 9.3.13.4. Market Size and Forecast, By Type
        • 9.3.13.5. Market Size and Forecast, By End User
      • 9.3.14. Rest Of Europe Neurology Software Market

        • 9.3.14.1. Market Size and Forecast, By Component
        • 9.3.14.2. Market Size and Forecast, By Deployment Model
        • 9.3.14.3. Market Size and Forecast, By Enterprise Size
        • 9.3.14.4. Market Size and Forecast, By Type
        • 9.3.14.5. Market Size and Forecast, By End User
    • 9.4. Asia-Pacific

      • 9.4.1. Key Market Trends and Opportunities

      • 9.4.2. Market Size and Forecast, By Component

      • 9.4.3. Market Size and Forecast, By Deployment Model

      • 9.4.4. Market Size and Forecast, By Enterprise Size

      • 9.4.5. Market Size and Forecast, By Type

      • 9.4.6. Market Size and Forecast, By End User

      • 9.4.7. Market Size and Forecast, By Country

      • 9.4.8. China Neurology Software Market

        • 9.4.8.1. Market Size and Forecast, By Component
        • 9.4.8.2. Market Size and Forecast, By Deployment Model
        • 9.4.8.3. Market Size and Forecast, By Enterprise Size
        • 9.4.8.4. Market Size and Forecast, By Type
        • 9.4.8.5. Market Size and Forecast, By End User
      • 9.4.9. Japan Neurology Software Market

        • 9.4.9.1. Market Size and Forecast, By Component
        • 9.4.9.2. Market Size and Forecast, By Deployment Model
        • 9.4.9.3. Market Size and Forecast, By Enterprise Size
        • 9.4.9.4. Market Size and Forecast, By Type
        • 9.4.9.5. Market Size and Forecast, By End User
      • 9.4.10. India Neurology Software Market

        • 9.4.10.1. Market Size and Forecast, By Component
        • 9.4.10.2. Market Size and Forecast, By Deployment Model
        • 9.4.10.3. Market Size and Forecast, By Enterprise Size
        • 9.4.10.4. Market Size and Forecast, By Type
        • 9.4.10.5. Market Size and Forecast, By End User
      • 9.4.11. South Korea Neurology Software Market

        • 9.4.11.1. Market Size and Forecast, By Component
        • 9.4.11.2. Market Size and Forecast, By Deployment Model
        • 9.4.11.3. Market Size and Forecast, By Enterprise Size
        • 9.4.11.4. Market Size and Forecast, By Type
        • 9.4.11.5. Market Size and Forecast, By End User
      • 9.4.12. Australia Neurology Software Market

        • 9.4.12.1. Market Size and Forecast, By Component
        • 9.4.12.2. Market Size and Forecast, By Deployment Model
        • 9.4.12.3. Market Size and Forecast, By Enterprise Size
        • 9.4.12.4. Market Size and Forecast, By Type
        • 9.4.12.5. Market Size and Forecast, By End User
      • 9.4.13. Thailand Neurology Software Market

        • 9.4.13.1. Market Size and Forecast, By Component
        • 9.4.13.2. Market Size and Forecast, By Deployment Model
        • 9.4.13.3. Market Size and Forecast, By Enterprise Size
        • 9.4.13.4. Market Size and Forecast, By Type
        • 9.4.13.5. Market Size and Forecast, By End User
      • 9.4.14. Malaysia Neurology Software Market

        • 9.4.14.1. Market Size and Forecast, By Component
        • 9.4.14.2. Market Size and Forecast, By Deployment Model
        • 9.4.14.3. Market Size and Forecast, By Enterprise Size
        • 9.4.14.4. Market Size and Forecast, By Type
        • 9.4.14.5. Market Size and Forecast, By End User
      • 9.4.15. Indonesia Neurology Software Market

        • 9.4.15.1. Market Size and Forecast, By Component
        • 9.4.15.2. Market Size and Forecast, By Deployment Model
        • 9.4.15.3. Market Size and Forecast, By Enterprise Size
        • 9.4.15.4. Market Size and Forecast, By Type
        • 9.4.15.5. Market Size and Forecast, By End User
      • 9.4.16. Rest of Asia Pacific Neurology Software Market

        • 9.4.16.1. Market Size and Forecast, By Component
        • 9.4.16.2. Market Size and Forecast, By Deployment Model
        • 9.4.16.3. Market Size and Forecast, By Enterprise Size
        • 9.4.16.4. Market Size and Forecast, By Type
        • 9.4.16.5. Market Size and Forecast, By End User
    • 9.5. LAMEA

      • 9.5.1. Key Market Trends and Opportunities

      • 9.5.2. Market Size and Forecast, By Component

      • 9.5.3. Market Size and Forecast, By Deployment Model

      • 9.5.4. Market Size and Forecast, By Enterprise Size

      • 9.5.5. Market Size and Forecast, By Type

      • 9.5.6. Market Size and Forecast, By End User

      • 9.5.7. Market Size and Forecast, By Country

      • 9.5.8. Brazil Neurology Software Market

        • 9.5.8.1. Market Size and Forecast, By Component
        • 9.5.8.2. Market Size and Forecast, By Deployment Model
        • 9.5.8.3. Market Size and Forecast, By Enterprise Size
        • 9.5.8.4. Market Size and Forecast, By Type
        • 9.5.8.5. Market Size and Forecast, By End User
      • 9.5.9. South Africa Neurology Software Market

        • 9.5.9.1. Market Size and Forecast, By Component
        • 9.5.9.2. Market Size and Forecast, By Deployment Model
        • 9.5.9.3. Market Size and Forecast, By Enterprise Size
        • 9.5.9.4. Market Size and Forecast, By Type
        • 9.5.9.5. Market Size and Forecast, By End User
      • 9.5.10. Saudi Arabia Neurology Software Market

        • 9.5.10.1. Market Size and Forecast, By Component
        • 9.5.10.2. Market Size and Forecast, By Deployment Model
        • 9.5.10.3. Market Size and Forecast, By Enterprise Size
        • 9.5.10.4. Market Size and Forecast, By Type
        • 9.5.10.5. Market Size and Forecast, By End User
      • 9.5.11. UAE Neurology Software Market

        • 9.5.11.1. Market Size and Forecast, By Component
        • 9.5.11.2. Market Size and Forecast, By Deployment Model
        • 9.5.11.3. Market Size and Forecast, By Enterprise Size
        • 9.5.11.4. Market Size and Forecast, By Type
        • 9.5.11.5. Market Size and Forecast, By End User
      • 9.5.12. Argentina Neurology Software Market

        • 9.5.12.1. Market Size and Forecast, By Component
        • 9.5.12.2. Market Size and Forecast, By Deployment Model
        • 9.5.12.3. Market Size and Forecast, By Enterprise Size
        • 9.5.12.4. Market Size and Forecast, By Type
        • 9.5.12.5. Market Size and Forecast, By End User
      • 9.5.13. Rest of LAMEA Neurology Software Market

        • 9.5.13.1. Market Size and Forecast, By Component
        • 9.5.13.2. Market Size and Forecast, By Deployment Model
        • 9.5.13.3. Market Size and Forecast, By Enterprise Size
        • 9.5.13.4. Market Size and Forecast, By Type
        • 9.5.13.5. Market Size and Forecast, By End User
  • CHAPTER 10: COMPETITIVE LANDSCAPE

    • 10.1. Introduction

    • 10.2. Top Winning Strategies

    • 10.3. Product Mapping Of Top 10 Player

    • 10.4. Competitive Dashboard

    • 10.5. Competitive Heatmap

    • 10.6. Top Player Positioning, 2024

  • CHAPTER 11: COMPANY PROFILES

    • 11.1. Epic Neuro Inc

      • 11.1.1. Company Overview

      • 11.1.2. Key Executives

      • 11.1.3. Company Snapshot

      • 11.1.4. Operating Business Segments

      • 11.1.5. Product Portfolio

      • 11.1.6. Business Performance

      • 11.1.7. Key Strategic Moves and Developments

    • 11.2. Athenahealth

      • 11.2.1. Company Overview

      • 11.2.2. Key Executives

      • 11.2.3. Company Snapshot

      • 11.2.4. Operating Business Segments

      • 11.2.5. Product Portfolio

      • 11.2.6. Business Performance

      • 11.2.7. Key Strategic Moves and Developments

    • 11.3. NextGen Healthcare Information Systems LLC

      • 11.3.1. Company Overview

      • 11.3.2. Key Executives

      • 11.3.3. Company Snapshot

      • 11.3.4. Operating Business Segments

      • 11.3.5. Product Portfolio

      • 11.3.6. Business Performance

      • 11.3.7. Key Strategic Moves and Developments

    • 11.4. HealthFusion Inc.

      • 11.4.1. Company Overview

      • 11.4.2. Key Executives

      • 11.4.3. Company Snapshot

      • 11.4.4. Operating Business Segments

      • 11.4.5. Product Portfolio

      • 11.4.6. Business Performance

      • 11.4.7. Key Strategic Moves and Developments

    • 11.5. Allscripts Healthcare Solutions Inc.

      • 11.5.1. Company Overview

      • 11.5.2. Key Executives

      • 11.5.3. Company Snapshot

      • 11.5.4. Operating Business Segments

      • 11.5.5. Product Portfolio

      • 11.5.6. Business Performance

      • 11.5.7. Key Strategic Moves and Developments

    • 11.6. Greenway Health LLC

      • 11.6.1. Company Overview

      • 11.6.2. Key Executives

      • 11.6.3. Company Snapshot

      • 11.6.4. Operating Business Segments

      • 11.6.5. Product Portfolio

      • 11.6.6. Business Performance

      • 11.6.7. Key Strategic Moves and Developments

    • 11.7. Practice Fusion Inc

      • 11.7.1. Company Overview

      • 11.7.2. Key Executives

      • 11.7.3. Company Snapshot

      • 11.7.4. Operating Business Segments

      • 11.7.5. Product Portfolio

      • 11.7.6. Business Performance

      • 11.7.7. Key Strategic Moves and Developments

    • 11.8. Brainlab AG

      • 11.8.1. Company Overview

      • 11.8.2. Key Executives

      • 11.8.3. Company Snapshot

      • 11.8.4. Operating Business Segments

      • 11.8.5. Product Portfolio

      • 11.8.6. Business Performance

      • 11.8.7. Key Strategic Moves and Developments

    • 11.9. Kareo Inc

      • 11.9.1. Company Overview

      • 11.9.2. Key Executives

      • 11.9.3. Company Snapshot

      • 11.9.4. Operating Business Segments

      • 11.9.5. Product Portfolio

      • 11.9.6. Business Performance

      • 11.9.7. Key Strategic Moves and Developments

    • 11.10. Bizmatics

      • 11.10.1. Company Overview

      • 11.10.2. Key Executives

      • 11.10.3. Company Snapshot

      • 11.10.4. Operating Business Segments

      • 11.10.5. Product Portfolio

      • 11.10.6. Business Performance

      • 11.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY SOFTWARE MARKET, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NEUROLOGY SOFTWARE MARKET FOR SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NEUROLOGY SOFTWARE MARKET FOR SERVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NEUROLOGY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NEUROLOGY SOFTWARE MARKET FOR ON-PREMISES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NEUROLOGY SOFTWARE MARKET FOR CLOUD, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NEUROLOGY SOFTWARE MARKET, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NEUROLOGY SOFTWARE MARKET FOR LARGE ENTERPRISES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NEUROLOGY SOFTWARE MARKET FOR SMALL AND MEDIUM ENTERPRISES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NEUROLOGY SOFTWARE MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NEUROLOGY SOFTWARE MARKET FOR TYPE I, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL NEUROLOGY SOFTWARE MARKET FOR TYPE II, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL NEUROLOGY SOFTWARE MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL NEUROLOGY SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL NEUROLOGY SOFTWARE MARKET FOR COLLEGE AND RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL NEUROLOGY SOFTWARE MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL NEUROLOGY SOFTWARE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA NEUROLOGY SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. U.S. NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 25. U.S. NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 26. U.S. NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 27. U.S. NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. U.S. NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. CANADA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 30. CANADA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 31. CANADA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 32. CANADA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. CANADA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. MEXICO NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 35. MEXICO NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 36. MEXICO NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 37. MEXICO NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. MEXICO NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. EUROPE NEUROLOGY SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 40. EUROPE NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 41. EUROPE NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 42. EUROPE NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 43. EUROPE NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. EUROPE NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. FRANCE NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 46. FRANCE NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 47. FRANCE NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 48. FRANCE NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. FRANCE NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. GERMANY NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 51. GERMANY NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 52. GERMANY NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 53. GERMANY NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. GERMANY NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. ITALY NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 56. ITALY NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 57. ITALY NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 58. ITALY NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. ITALY NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. SPAIN NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 61. SPAIN NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 62. SPAIN NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 63. SPAIN NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SPAIN NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. UK NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 66. UK NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 67. UK NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 68. UK NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. UK NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. RUSSIA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 71. RUSSIA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 72. RUSSIA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 73. RUSSIA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. RUSSIA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 75. REST OF EUROPE NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 76. REST OF EUROPE NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 77. REST OF EUROPE NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 78. REST OF EUROPE NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 79. REST OF EUROPE NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. ASIA-PACIFIC NEUROLOGY SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 81. ASIA-PACIFIC NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 82. ASIA-PACIFIC NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 83. ASIA-PACIFIC NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 84. ASIA-PACIFIC NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 85. ASIA-PACIFIC NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 86. CHINA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 87. CHINA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 88. CHINA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 89. CHINA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 90. CHINA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 91. JAPAN NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 92. JAPAN NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 93. JAPAN NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 94. JAPAN NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 95. JAPAN NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. INDIA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 97. INDIA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 98. INDIA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 99. INDIA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 100. INDIA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 101. SOUTH KOREA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 102. SOUTH KOREA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 103. SOUTH KOREA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 104. SOUTH KOREA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 105. SOUTH KOREA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 106. AUSTRALIA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 107. AUSTRALIA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 108. AUSTRALIA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 109. AUSTRALIA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 110. AUSTRALIA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 111. THAILAND NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 112. THAILAND NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 113. THAILAND NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 114. THAILAND NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 115. THAILAND NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 116. MALAYSIA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 117. MALAYSIA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 118. MALAYSIA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 119. MALAYSIA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 120. MALAYSIA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 121. INDONESIA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 122. INDONESIA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 123. INDONESIA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 124. INDONESIA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 125. INDONESIA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 126. REST OF ASIA PACIFIC NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 127. REST OF ASIA PACIFIC NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 128. REST OF ASIA PACIFIC NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 129. REST OF ASIA PACIFIC NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 130. REST OF ASIA PACIFIC NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 131. LAMEA NEUROLOGY SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 132. LAMEA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 133. LAMEA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 134. LAMEA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 135. LAMEA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 136. LAMEA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 137. BRAZIL NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 138. BRAZIL NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 139. BRAZIL NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 140. BRAZIL NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 141. BRAZIL NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 142. SOUTH AFRICA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 143. SOUTH AFRICA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 144. SOUTH AFRICA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 145. SOUTH AFRICA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 146. SOUTH AFRICA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 147. SAUDI ARABIA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 148. SAUDI ARABIA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 149. SAUDI ARABIA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 150. SAUDI ARABIA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 151. SAUDI ARABIA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 152. UAE NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 153. UAE NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 154. UAE NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 155. UAE NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 156. UAE NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 157. ARGENTINA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 158. ARGENTINA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 159. ARGENTINA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 160. ARGENTINA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 161. ARGENTINA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 162. REST OF LAMEA NEUROLOGY SOFTWARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 163. REST OF LAMEA NEUROLOGY SOFTWARE, BY DEPLOYMENT MODEL, 2025-2033 ($MILLION)
  • TABLE 164. REST OF LAMEA NEUROLOGY SOFTWARE, BY ENTERPRISE SIZE, 2025-2033 ($MILLION)
  • TABLE 165. REST OF LAMEA NEUROLOGY SOFTWARE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 166. REST OF LAMEA NEUROLOGY SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 167. EPIC NEURO INC: KEY EXECUTIVES
  • TABLE 168. EPIC NEURO INC: COMPANY SNAPSHOT
  • TABLE 169. EPIC NEURO INC: OPERATING SEGMENTS
  • TABLE 170. EPIC NEURO INC: PRODUCT PORTFOLIO
  • TABLE 171. EPIC NEURO INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. ATHENAHEALTH: KEY EXECUTIVES
  • TABLE 173. ATHENAHEALTH: COMPANY SNAPSHOT
  • TABLE 174. ATHENAHEALTH: OPERATING SEGMENTS
  • TABLE 175. ATHENAHEALTH: PRODUCT PORTFOLIO
  • TABLE 176. ATHENAHEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: KEY EXECUTIVES
  • TABLE 178. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: COMPANY SNAPSHOT
  • TABLE 179. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: OPERATING SEGMENTS
  • TABLE 180. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: PRODUCT PORTFOLIO
  • TABLE 181. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. HEALTHFUSION INC.: KEY EXECUTIVES
  • TABLE 183. HEALTHFUSION INC.: COMPANY SNAPSHOT
  • TABLE 184. HEALTHFUSION INC.: OPERATING SEGMENTS
  • TABLE 185. HEALTHFUSION INC.: PRODUCT PORTFOLIO
  • TABLE 186. HEALTHFUSION INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 187. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: KEY EXECUTIVES
  • TABLE 188. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: COMPANY SNAPSHOT
  • TABLE 189. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: OPERATING SEGMENTS
  • TABLE 190. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: PRODUCT PORTFOLIO
  • TABLE 191. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 192. GREENWAY HEALTH LLC: KEY EXECUTIVES
  • TABLE 193. GREENWAY HEALTH LLC: COMPANY SNAPSHOT
  • TABLE 194. GREENWAY HEALTH LLC: OPERATING SEGMENTS
  • TABLE 195. GREENWAY HEALTH LLC: PRODUCT PORTFOLIO
  • TABLE 196. GREENWAY HEALTH LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 197. PRACTICE FUSION INC: KEY EXECUTIVES
  • TABLE 198. PRACTICE FUSION INC: COMPANY SNAPSHOT
  • TABLE 199. PRACTICE FUSION INC: OPERATING SEGMENTS
  • TABLE 200. PRACTICE FUSION INC: PRODUCT PORTFOLIO
  • TABLE 201. PRACTICE FUSION INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 202. BRAINLAB AG: KEY EXECUTIVES
  • TABLE 203. BRAINLAB AG: COMPANY SNAPSHOT
  • TABLE 204. BRAINLAB AG: OPERATING SEGMENTS
  • TABLE 205. BRAINLAB AG: PRODUCT PORTFOLIO
  • TABLE 206. BRAINLAB AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 207. KAREO INC: KEY EXECUTIVES
  • TABLE 208. KAREO INC: COMPANY SNAPSHOT
  • TABLE 209. KAREO INC: OPERATING SEGMENTS
  • TABLE 210. KAREO INC: PRODUCT PORTFOLIO
  • TABLE 211. KAREO INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 212. BIZMATICS: KEY EXECUTIVES
  • TABLE 213. BIZMATICS: COMPANY SNAPSHOT
  • TABLE 214. BIZMATICS: OPERATING SEGMENTS
  • TABLE 215. BIZMATICS: PRODUCT PORTFOLIO
  • TABLE 216. BIZMATICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY SOFTWARE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROLOGY SOFTWARE MARKET
  • FIGURE 3. SEGMENTATION NEUROLOGY SOFTWARE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROLOGY SOFTWARE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROLOGY SOFTWARE MARKET
  • FIGURE 11. NEUROLOGY SOFTWARE MARKET SEGMENTATION, BY BY COMPONENT
  • FIGURE 12. NEUROLOGY SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NEUROLOGY SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NEUROLOGY SOFTWARE MARKET SEGMENTATION, BY BY DEPLOYMENT MODEL
  • FIGURE 15. NEUROLOGY SOFTWARE MARKET FOR ON-PREMISES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. NEUROLOGY SOFTWARE MARKET FOR CLOUD, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. NEUROLOGY SOFTWARE MARKET SEGMENTATION, BY BY ENTERPRISE SIZE
  • FIGURE 18. NEUROLOGY SOFTWARE MARKET FOR LARGE ENTERPRISES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. NEUROLOGY SOFTWARE MARKET FOR SMALL AND MEDIUM ENTERPRISES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. NEUROLOGY SOFTWARE MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 21. NEUROLOGY SOFTWARE MARKET FOR TYPE I, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. NEUROLOGY SOFTWARE MARKET FOR TYPE II, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. NEUROLOGY SOFTWARE MARKET SEGMENTATION, BY BY END USER
  • FIGURE 24. NEUROLOGY SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. NEUROLOGY SOFTWARE MARKET FOR COLLEGE AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. NEUROLOGY SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 31. COMPETITIVE DASHBOARD
  • FIGURE 32. COMPETITIVE HEATMAP: NEUROLOGY SOFTWARE MARKET
  • FIGURE 33. TOP PLAYER POSITIONING, 2024
  • FIGURE 34. EPIC NEURO INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. EPIC NEURO INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. EPIC NEURO INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. ATHENAHEALTH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. ATHENAHEALTH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. ATHENAHEALTH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. NEXTGEN HEALTHCARE INFORMATION SYSTEMS LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. HEALTHFUSION INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. HEALTHFUSION INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. HEALTHFUSION INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. GREENWAY HEALTH LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. GREENWAY HEALTH LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. GREENWAY HEALTH LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. PRACTICE FUSION INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. PRACTICE FUSION INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. PRACTICE FUSION INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. BRAINLAB AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. BRAINLAB AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. BRAINLAB AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. KAREO INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. KAREO INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. KAREO INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. BIZMATICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. BIZMATICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. BIZMATICS: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Neurology Software Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue